A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults
Abroad (travel likely)RecruitingPHASE1
Conditions
Healthy Participants · Healthy Adult Females · Healthy Adult Male · Healthy · Volunteer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Scientia Clinical Research Ltd, Sydney, New South Wales, Australia
Contact: Principal Investigator (Christopher Argent)